Episode 85: Essential Cardiovascular Risk Laboratory Analysis with Dr. Thomas Dayspring
Dr. Kara Fitzgerald | New Frontiers in Functional Medicine, Longevity, Epigenetics
English - June 04, 2020 18:44 - 1 hour - 61.1 MB - ★★★★★ - 217 ratingsHealth & Fitness fitness lifestyle nutrition weightloss exercise wellness diet health muscle menopause Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
What a superb conversation with leading expert lipidologist and – importantly – clinician of 30+ years, Tom Dayspring, MD. In this tour-de-force conversation, we break down the essential cardiovascular risk laboratory analysis you need to be undertaking on all your patients. We spend a little extra time on Lp(a) and the coronary calcium score. Our conversation is practical; I was fervently taking notes through the entire recording, as I suspect you’ll be doing. I will likely bring Tom back for additional conversation, perhaps focusing on women’s cardiovascular health, so stay tuned!
As with many of my podcasts, I chat with my guests before and after the recording. Tom and I discuss on the podcast whether we’re concerned about brain cholesterol deficits with an excessively lowered LDL. He unequivocally stated not; we synthesize all the cholesterol we need locally, including in the CNS. However, after the recording, he added that statins can cross the BBB and lower brain cholesterol. Serum desmosterol is an analyte that can readily be assessed that is a surrogate marker of brain cholesterol: consider this if needed.
Enjoy this in-depth conversation, and be sure to leave New Frontiers a rating on iTunes or Stitcher or wherever you listen. It’s the best thing you can do to help share this valuable content and help put FxMed in front of more and more listeners! Thank you! ~DrKF